首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway
【24h】

LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway

机译:LC和LC-MS / MS研究,用于鉴定和表征IBRUTINIB新的降解产物,并阐明其降解途径

获取原文
获取原文并翻译 | 示例
           

摘要

Forced degradation/stress degradation studies of ibrutinib drug were done in hydrolytic (acidic, alkaline and neutral), thermal, photolytic and oxidative degradation conditions in different temperature conditions as per International Conference on Harmonization (ICH) guideline Q1A(R2) in order to identify and characterize degradation products (DPs) of ibrutinib.
机译:根据国际协调会议(ICH)指南Q1A(R2),在不同温度条件下,在水解(酸性、碱性和中性)、热降解、光解和氧化降解条件下对伊布替尼药物进行强制降解/应激降解研究,以确定和表征伊布替尼的降解产物(DPs)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号